Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study.

Autor:	Maraveyas, A.1, Sgouros, J.1, Upadhyay, S.2, Abdel-Hamid, A-H.2, Holmes, M.2, Lind, M.1
Zdroj:	British Journal of Cancer. 3/14/2005, Vol. 92 Issue 5, p815-819. 5p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu